P. Johansen

发表

Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine

S. Jensen, P. Johansen, S. Rasmussen, 2004, Cancer Chemotherapy and Pharmacology.

Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse

P. Johansen, 2004, Cancer Chemotherapy and Pharmacology.

Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs

J. Veldhuis, M. Ankersen, P. Johansen, 2007, Endocrine.

Adipogenic and orexigenic effects of the ghrelin-receptor ligand tabimorelin are diminished in leptin-signalling-deficient ZDF rats.

J. Rømer, P. Johansen, I. Ahnfelt-Rønne, 2004, European journal of endocrinology.

Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

J. Holst, R. Pederson, C. Mcintosh, 2009, American journal of physiology. Endocrinology and metabolism.

Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass.

J. Holst, R. Pederson, C. Mcintosh, 2009, American journal of physiology. Endocrinology and metabolism.

Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model

K. Almholt, M. Loftager, M. Kreilgaard, 2018, Journal of thrombosis and haemostasis : JTH.

A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.

L. Thim, H. Rahbek-Nielsen, E. Persson, 2013, Blood.

THROMBOSIS AND HEMOSTASIS A novel B-domain O-glycoPEGylated FVIII ( N 8-GP ) demonstrates full ef fi cacy and prolonged effect in hemophilic mice models

L. Thim, H. Rahbek-Nielsen, E. Persson, 2013 .

Effects of heparin and aminoguanidine on glomerular basement membrane thickening in diabetic rats

H. Yokoyama, P. Oturai, T. Deckert, 1996, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats.

N. Tygstrup, H. Grønbaek, J. Greisen, 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Increase of Neuronal Histamine in Obese Rats Is Associated with Decreases in Body Weight and Plasma Triglycerides

H. H. Refsgaard, K. Rimvall, V. Golozoubova, 2006, Obesity.

Studies on the Renal Kinetics of Growth Hormone (GH) and on the GH Receptor and Related Effects in Animals

C. Friis, P. Johansen, J. Nowak, 1994, Journal of Pediatric Endocrinology.

Recombinant human factor VIIa and a factor VIIa‐analogue reduces heparin and low molecular weight heparin (LMWH)‐induced bleeding in rats

P. Johansen, U. Hedner, B. Lauritzen, 2008, Journal of thrombosis and haemostasis : JTH.

efficacy and prolonged effect in hemophilic mice models A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full

H. Rahbek-Nielsen, P. Johansen, F. Rode, 2013 .

Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis.

T. Bateman, P. Monahan, D. Monroe, 2017, Blood.

Absorption and metabolism of the absorption enhancer didecanoylphosphatidylcholine in rabbit nasal epithelium in vivo.

H. Hansen, C. Vermehren, P. Johansen, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacological characterisation of a new oral GH secretagogue, NN703.

K. Raun, T. Hansen, M. Ankersen, 1999, European journal of endocrinology.

Epithelial Transport and Bioavailability of Intranasally Administered Human Growth Hormone Formulated with the Absorption Enhancers Didecanoy‐L‐α‐phosphatidylcholine and α‐Cyclodextrin in Rabbits

P. Johansen, L. Bastholm, M. Nielsen, 1994 .

The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats.

N. B. Andersen, H. Oxlund, T. Andreassen, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Factor VIII with a 237 amino acid B‐domain has an extended half‐life in F8‐knockout mice

L. Thim, H. Rahbek-Nielsen, M. Loftager, 2019, Journal of thrombosis and haemostasis : JTH.

Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation.

P. Johansen, S. Rasmussen, E. Johansson, 2009, Acta pharmacologica et toxicologica.

Prolonged effect of GlycoPEGylated rFVIIa (40k-PEG-rFVIIa) in rabbits correlates to activity in plasma

I. Thorup, H. Stennicke, P. Johansen, 2010, Thrombosis and Haemostasis.

Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia

A. Mast, Catherine E. Bonesho, P. Johansen, 2012, Proceedings of the National Academy of Sciences.

Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice – characterization of two novel FVIII molecules

P. Johansen, M. Tranholm, J. Haaning, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats.

P. Ostergaard, P. Johansen, S. Rasmussen, 1994, Thrombosis research.

Pharmacological characterization of a biosynthetic trisulfide-containing hydrophobic derivative of human growth hormone: comparison with standard 22 K growth hormone.

P Nilsson, P. Thomsen, B. S. Hansen, 1994, Pharmacology & toxicology.

Comparison of methods of analysis of body composition in hypophysectomized rats treated with rat growth hormone.

A. Flyvbjerg, M. Wilken, P. Johansen, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

H. Orskov, A. Flyvbjerg, M. Wilken, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Growth Hormone (GH) Hypersecretion and GH Receptor Resistance in Streptozotocin Diabetic Mice in Response to a GH Secretagogue

M. Phillip, D. Landau, Y. Segev, 2003, Experimental diabesity research.

Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight

H. H. Refsgaard, B. Wulff, K. Raun, 2005, International Journal of Obesity.

Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice

J. Holst, P. Serup, D. S. Dichmann, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Automated registration of tail bleeding in rats

P. Johansen, B. Lauritzen, M. Tranholm, 2008, Thrombosis and Haemostasis.

Risk stratification of patients suspected of coronary artery disease: comparison of five different models.

J. Jensen, B. Nørgaard, P. Johansen, 2012, Atherosclerosis.

Prophylactic administration of glycoPEGylated factor IX provides protection and joint outcome superior to recombinant factor IX after induced joint bleeding

T. Bateman, P. Monahan, M. L. Broberg, 2019, Journal of thrombosis and haemostasis : JTH.

Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.

H. Oxlund, M. Wilken, P. Johansen, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers

P. Munkholm, P. Johansen, S. Rasmussen, 1994, European journal of drug metabolism and pharmacokinetics.